Search
Close this search box.

Aflibercept biosimilars – update on the development progress – Eye

Competing interests

AS—consultant: Novartis, Allergan, Bayer, Lupin and Intas and speaker fee: Biogen. AL—consultant: Allergan, Novartis, Roche, Notal Vision, ForSight Labs, Beyeonics, Bayer Health Care. NP—None. NK—None. FB—consultant: Allergan, Bayer, Boehringer Ingelheim, FidiaSooft, Hofmann La Roche, Novartis, NTC Pharma, Sifi, Thrombogenics, Zeiss. BDK—clinical research: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics and consultant: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, Theravance Biopharma.